Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cannara Biotech Inc (OP:LOVFF)

1.301 -0.003 (-0.23%)
Streaming Delayed Price Updated: 2:56 PM EST, Dec 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Cannara Biotech Inc

News headline image
Cannara Announces Proposed Settlement of Convertible Debenture via Share Issuance
From Cannara Biotech (Québec) Inc.
Via GlobeNewswire
News headline image
Presenting at the Investor Summit Q3 2025 on September 16; Watch the Live Stream for Free
Via ACCESS Newswire
News headline image
Cannara Announces Grant of Options and RSUs
From Cannara Biotech (Québec) Inc.
Via GlobeNewswire
News headline image
Cannara Biotech Delivers Highest Revenue and Profitability Since Inception in Fiscal Q3 2025
From Cannara Biotech (Québec) Inc.
Via GlobeNewswire
News headline image
Cannara Announces Amendment and Upsize of BMO Credit Facility to Support Facility Expansion at Valleyfield
Expanded credit facility to fund initial post-harvest buildout at Valleyfield, supporting the Company’s long-term goal of reaching 100,000 kg annual capacity 
From Cannara Biotech (Québec) Inc.
Via GlobeNewswire
News headline image
Cannara Biotech Delivers Record Q2 Results as National Expansion Accelerates
From Cannara Biotech (Québec) Inc.
Via GlobeNewswire
News headline image
Cannara Biotech Enhances Financial Flexibility Through Strategic Asset Sale
From Cannara Biotech (Québec) Inc.
Via GlobeNewswire
News headline image
Cannara Biotech to Present at The Ventum Canadian Cannabis Conference on March 12th, 2025
From Cannara Biotech (Québec) Inc.
Via GlobeNewswire
News headline image
Cannara Secures 5 Key Listings in Québec’s New Vape Cartridge Category Including to be Released Live Rosin Vapes
From Cannara Biotech (Québec) Inc.
Via GlobeNewswire
News headline image
Cannara Biotech Reports Record Q1 2025 Revenue and National Market Share, Sets Stage for Continued Momentum in 2025
From Cannara Biotech (Québec) Inc.
Via GlobeNewswire
News headline image
Cannara Biotech Inc. to Announce Fiscal Q3 2025 Financial Results on July 28, 2025
From Cannara Biotech (Québec) Inc.
Via GlobeNewswire
News headline image
Cannara Biotech to Host Investor Webcast on Thursday December 19th, 2024
From Cannara Biotech (Québec) Inc.
Via GlobeNewswire
News headline image
Cannara Biotech to Host Investor Webcast on June 25th, 2025
From Cannara Biotech (Québec) Inc.
Via GlobeNewswire
News headline image
Cannara Biotech Inc. Reports Q4 and Fiscal Year 2024 Results: Achieves Record Sales Growth and Operating Cash Flow, Solidifying Leadership in Canada's Cannabis Market
From Cannara Biotech (Québec) Inc.
Via GlobeNewswire
News headline image
Cannara Reduces Cost of Debt with Lower Interest Rate and Partial Debenture Repayment; Wins 2025 Brand of the Year
From Cannara Biotech (Québec) Inc.
Via GlobeNewswire
News headline image
Cannara Biotech Reports Q3 2024 Financial Results
From Cannara Biotech (Québec) Inc.
Via GlobeNewswire
News headline image
Cannara Biotech Inc. to Announce Fiscal Q2 2025 Financial Results on April 28, 2025
From Cannara Biotech (Québec) Inc.
Via GlobeNewswire
News headline image
Cannara Biotech Announces Appointment of Justin Cohen to Board of Directors
From Cannara Biotech (Québec) Inc.
Via GlobeNewswire
News headline image
Cannara Announces Extension of BMO Credit Facility and Convertible Debenture to Enhance Financial Flexibility and Support Execution of its Long-Term Strategy
From Cannara Biotech (Québec) Inc.
Via GlobeNewswire
News headline image
Cannara Provides Update on Its 2024 Annual General Meeting Materials amid Canada Post Strike
From Cannara Biotech (Québec) Inc.
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.